These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10952089)

  • 41. A novel measure characterized by a polar energy surface approximation for recognition and classification of transmembrane protein structures.
    Suwa M; Yudate HT; Masuho Y; Mitaku S
    Proteins; 2000 Dec; 41(4):504-17. PubMed ID: 11056038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cloning, expression, sequence determination, and chromosome localization of the mouse complement C3a anaphylatoxin receptor gene.
    Hollmann TJ; Haviland DL; Kildsgaard J; Watts K; Wetsel RA
    Mol Immunol; 1998 Feb; 35(3):137-48. PubMed ID: 9694514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydrophobic organization of alpha-helix membrane bundle in bacteriorhodopsin.
    Efremov RG; Vergoten G
    J Protein Chem; 1996 Jan; 15(1):63-76. PubMed ID: 8838591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of receptor/ligand interactions using whole-molecule randomly-mutated ligand libraries.
    Cain SA; Ratcliffe CF; Williams DM; Harris V; Monk PN
    J Immunol Methods; 2000 Nov; 245(1-2):139-45. PubMed ID: 11042291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C5aR ligand peptide 3D QSAR study performed with an applied linear conformation.
    Anderson CY; Kellogg GE; Freer RJ
    J Pept Res; 1997 Jun; 49(6):476-83. PubMed ID: 9266474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A model for the C5a receptor and for its interaction with the ligand [corrected].
    Grötzinger J; Engels M; Jacoby E; Wollmer A; Strassburger W
    Protein Eng; 1991 Oct; 4(7):767-71. PubMed ID: 1665906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequence divergence analysis for the prediction of seven-helix membrane protein structures: I. Comparison with bacteriorhodopsin.
    Du P; Alkorta I
    Protein Eng; 1994 Oct; 7(10):1221-9. PubMed ID: 7855137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A neural network model for the prediction of membrane-spanning amino acid sequences.
    Lohmann R; Schneider G; Behrens D; Wrede P
    Protein Sci; 1994 Sep; 3(9):1597-601. PubMed ID: 7833818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding.
    Mery L; Boulay F
    Eur J Haematol; 1993 Nov; 51(5):282-7. PubMed ID: 8282089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of stability predictions and simulated unfolding of rhodopsin structures.
    Tastan O; Yu E; Ganapathiraju M; Aref A; Rader AJ; Klein-Seetharaman J
    Photochem Photobiol; 2007; 83(2):351-62. PubMed ID: 17576347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.
    Baldwin JM; Schertler GF; Unger VM
    J Mol Biol; 1997 Sep; 272(1):144-64. PubMed ID: 9299344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.
    Buck E; Wells JA
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2719-24. PubMed ID: 15710877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure of rhodopsin: A G protein-coupled receptor.
    Palczewski K; Kumasaka T; Hori T; Behnke CA; Motoshima H; Fox BA; Le Trong I; Teller DC; Okada T; Stenkamp RE; Yamamoto M; Miyano M
    Science; 2000 Aug; 289(5480):739-45. PubMed ID: 10926528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of the anaphylatoxin receptors, complement anaphylatoxin 3a receptor and complement anaphylatoxin 5a receptor, in the nasal mucosa of patients with mild and severe persistent allergic rhinitis.
    Jun SW; Kim TH; Lee HM; Lee SH; Kim WJ; Park SJ; Kim YS; Lee SH
    J Allergy Clin Immunol; 2008 Jul; 122(1):119-25. PubMed ID: 18538384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily.
    Seigneuret M
    Biophys J; 2006 Jan; 90(1):212-27. PubMed ID: 16352525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.